Preeclampsia Is Associated with Lower Production of Vascular Endothelial Growth Factor by Peripheral Blood Mononuclear Cells

• Published in: Archives of medical research Vol. 45; no. 7; pp. 561 - 569
• Main Authors: Cardenas-Mondragon, María G, Vallejo-Flores, Gabriela, Delgado-Dominguez, Jose, Romero-Arauz, Juan F, Gomez-Delgado, Alejandro, Aguilar-Madrid, Guadalupe, Sanchez-Barriga, Juan J, Marquez-Acosta, Janeth
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.10.2014
• Subjects: Adult; Cells, Cultured; Cross-Sectional Studies; Down-Regulation; Female; Gestational Age; Humans; Hypertensive disorders of pregnancy; Internal Medicine; Leukocytes, Mononuclear - metabolism; Longitudinal Studies; Pre-Eclampsia - blood; Pre-Eclampsia - metabolism; Preeclampsia; Pregnancy; Proteinuria - metabolism; sFlt-1; Vascular Endothelial Growth Factor A - antagonists & inhibitors; Vascular Endothelial Growth Factor A - biosynthesis; Vascular Endothelial Growth Factor A - blood; Vascular Endothelial Growth Factor Receptor-1 - blood; Vascular Endothelial Growth Factor Receptor-1 - metabolism; VEGF; sFlt-1; VEGF; Preeclampsia; Hypertensive disorders of pregnancy
• ISSN: 0188-4409; 1873-5487
• DOI: 10.1016/j.arcmed.2014.10.004

Background Recent studies show that vascular endothelial growth factor (VEGF) downregulation is implicated in preeclampsia (PE) pathophysiology. This study assessed the relationship between PE and VEGF levels produced by peripheral blood mononuclear cells (PBMCs) and their serum levels. Methods A cross-sectional design was performed in 36 patients who had hypertensive disorders during pregnancy. We also used a longitudinal design with 12 pregnant women with risk factors for PE development and/or abnormal uterine arteries by Doppler study. VEGF and soluble fms-like tyrosine kinase-1 (sFlt-1) levels were measured for all patients in both designs. Results sFlt-1 serum was higher in preeclamptic patients ( n  = 26), whereas VEGF produced by stimulated PBMCs was lower than in healthy pregnant women and VEGF levels produced by stimulated PBMCs were even lower ( p <0.003) in severe PE ( n  = 16). The receiver-operating characteristic curve analysis allowed establishing a cut-off value to identify patients with PE. VEGF production by PBMCs was 339.87 pg/mL. In addition, a robust linear regression model was performed to adjust the variance in VEGF levels. The patients' age decreased VEGF levels and was adjusted by weeks of gestation (WG) in our model. In the longitudinal study, 7/12 patients developed PE. VEGF produced by PBMCs cells was significantly lower in PE at 24–26 WG. Conclusions VEGF production by PBMCs is inhibited during PE, creating a downregulation of the microenvironment; this deficiency may contribute to the pathogenesis of disease.